Masimo Corp Files Definitive Additional Materials
Ticker: MASI · Form: DEFA14A · Filed: Jul 15, 2024 · CIK: 937556
| Field | Detail |
|---|---|
| Company | Masimo CORP (MASI) |
| Form Type | DEFA14A |
| Filed Date | Jul 15, 2024 |
| Risk Level | low |
| Pages | 9 |
| Reading Time | 11 min |
| Key Dollar Amounts | $100,000, $8 |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, sec-filing, definitive-additional-materials
TL;DR
Masimo Corp dropped more proxy docs, no fee, check it out.
AI Summary
Masimo Corporation filed definitive additional materials related to its proxy statement on July 15, 2024. This filing is an amendment to the proxy statement and does not require a fee. The company is incorporated in Delaware and its fiscal year ends on December 28.
Why It Matters
This filing indicates that Masimo Corporation is providing supplementary information to shareholders regarding matters to be voted on, which is crucial for informed decision-making by investors.
Risk Assessment
Risk Level: low — This filing is a routine administrative document related to proxy materials and does not contain new financial information or strategic changes that would inherently increase risk.
Key Players & Entities
- MASIMO CORP (company) — Registrant
- 0001213900-24-061180.txt (document) — Filing document identifier
- 20240715 (date) — Filing date
- DEFA14A (document) — Form type
FAQ
What type of SEC filing is this?
This is a DEFA14A filing, which stands for Definitive Additional Materials related to a proxy statement.
Who is the filing company?
The filing company is MASIMO CORP.
When was this filing submitted?
The filing was submitted on July 15, 2024.
Is there a fee associated with this filing?
No fee is required for this filing.
What is the SIC code for Masimo Corp?
The Standard Industrial Classification (SIC) code for Masimo Corp is 3845, which corresponds to Electromedical & Electrotherapeutic Apparatus.
Filing Stats: 2,732 words · 11 min read · ~9 pages · Grade level 12.1 · Accepted 2024-07-15 09:00:03
Key Financial Figures
- $100,000 — offey and each has been or will be paid $100,000 if elected. Politan director Michelle
- $8 — ed plan to achieve 30% EBIT margins and $8 earnings per share by 2029, which would
Filing Documents
- ea0209414-defa14a_masimo.htm (DEFA14A) — 59KB
- image_001.jpg (GRAPHIC) — 3KB
- 0001213900-24-061180.txt ( ) — 64KB
Forward-Looking Statements
Forward-Looking Statements This press release includes forward-looking as amended, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, among others, approval of the Board’s nominees, the proposed separation of Masimo’s consumer business, including any proposed joint venture transaction, and Masimo’s earnings per share, gross margin and EBIT margin estimates and targets. These forward-looking statements are based on current expectations about future events affecting Masimo and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond Masimo’s control and could cause its actual results to differ materially and adversely from those expressed in its forward-looking statements as a result of various risk factors, including, but not limited to (i) uncertainties regarding a potential separation of Masimo’s consumer business, including any proposed joint venture transaction, (ii) uncertainties regarding future actions that may be taken by Politan in furtherance of its nomination of director candidates for election at the 2024 Annual Meeting, (iii) the potential cost and management distraction attendant to Politan’s nomination of director nominees at the 2024 Annual Meeting and (iv) factors discussed in the “Risk Factors” section of Masimo’s most recent periodic reports filed with the Securities and Exchange Commission (“SEC”), which may be obtained for free at the SEC’s website at www.sec.gov . Although Masimo believes that the expectations reflected in its forward-looking statements are reasonable, the Company does not